GSK eyes replacing Human Genome board: sources – msnbc.com

May 30, 2012 Posted By: Leave a comment
Human Genome's by-laws allow its shareholders ... it would not proceed with its offer unless the U.S. company dropped a "poison pill" shareholder rights plan imposed to block any unwanted takeover. A Human Genome shareholder has filed a lawsuit against ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>